Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05787249 · ClinicalTrials.gov registry record · NA
Improving Utilization of Supplemental Breast MRI Screening for Women With Extremely Dense Breasts
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 1,358
- Enrollment target
NCT05787249: Completed NA study, sponsored by Abramson Cancer Center at Penn Medicine.
NCT05787249 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 1,358 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05787249, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,358 participants
- Enrollment target
Study Summary
The goal of this study is to increase MRI utilization among women with extremely dense breasts. The main question it seeks to answer is whether nudging of the provider, patient, or both increases the uptake of MRI among this group, and whether this effect differs between Black and White women.
Primary Outcome
Whether a breast MRI is ordered and/or scheduled within 6 months of receiving a nudge.
Interventions
- BEHAVIORAL Patient nudge
- BEHAVIORAL Provider nudge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,358 participants |
| Start Date | 2023-10-04 |
| Est. Completion | 2025-04-04 |
| Phase | NA |
What the finished NCT05787249 record still lists
NCT05787249 is an interventional study that assigns participants to a tested intervention. Its 1,358 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Patient nudge is the first listed.
NCT05787249 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05787249 about?
NCT05787249 is a clinical study titled "Improving Utilization of Supplemental Breast MRI Screening for Women With Extremely Dense Breasts". The goal of this study is to increase MRI utilization among women with extremely dense breasts. The main question it seeks to answer is whether nudging of the provider, patient, or both increases the uptake of MRI among this group, and whether this effect differs between Black and White women.
What is the current status of trial NCT05787249?
This trial is currently completed. It is a NA study. The enrollment target is 1,358 participants. The study started on 2023-10-04. Estimated completion is 2025-04-04.
What interventions are being tested in trial NCT05787249?
The interventions under investigation include: Patient nudge (BEHAVIORAL), Provider nudge (BEHAVIORAL).
Who is sponsoring clinical trial NCT05787249?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05787249's enrollment target sits among peer trials
1,358 73rd of 2000 higher than 1,928 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05245227 · 1,358 participants · Phase 3
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
- NCT02677064 · 1,365 participants
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
- NCT04489238 · 1,366 participants
Collection of Information to Better Understand Young Onset Colorectal Cancer
- NCT06318169 · 1,350 participants · Phase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI